A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer

NCT01147484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Breast Cancer

Interventions

DRUG: Foretinib

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]